New Canadian guideline for using GLP-1 agonists and SGLT2 inhibitors for cardiorenal risk reductionGLP-1 receptor agonists and SGLT2 inhibitors have proven cardiorenal benefits in patients with and without type 2 diabetes. QUIZ: Vascular anomalies in childhoodDo you know when and how to treat hemangiomas, and when to refer? Update to Canadian guidelines on managing pediatric dyslipidemia Provide an approach to the detection, evaluation and management of dyslipidemia in children and adolescents. Bad mix: hot summer days and anti-platelet medications, beta-blockers The meds plus heat associated with an increased risk for myocardial infraction. Pollution is linked to deadly heart arrhythmias Study indicates that people at high risk of ventricular arrhythmias should check daily pollution levels. QUIZ: Test your knowledge of detecting and managing dyslipidemia in children Should all children be screened for dyslipidemia? How much do you know about the detection and management of dyslipidemia in children and youth? Risk of myopericarditis with Pfizer COVID-19 vaccine in children 5 to 11 years Danish study examines risk of myopericarditis after COVID-19 vaccination in children, compared with adolescents and background incidence. Safe to drive after syncope? New Canadian research sheds light Researchers analyzed data from emergency department visits for first episodes of syncope. SARS-CoV-2 vaccination protects against heart attacks stroke after COVID-19 infection Cardiovascular event rates lower in vaccinated than non-vaccinated, even after breakthrough infections. Obesity and hypertension: a dangerous association for pregnancy Study shows higher risk of severe maternal morbidity and/or mortality for those overweight or obese. First Previous 18 19 20 21 22 Next Last
